Patents
Patents for A61P 7 - Drugs for disorders of the blood or the extracellular fluid (67,065)
01/1999
01/07/1999WO1999000371A1 Phenylalkyl derivatives with thrombin-inhibiting effect
01/07/1999WO1999000356A1 Substituted n-[(aminoiminomethyl or aminomethyl)phenyl]propyl amides
01/07/1999WO1999000128A1 Antithrombotic agents
01/07/1999WO1999000127A1 Antithrombotic agents
01/07/1999WO1999000126A1 Antithrombotic agents
01/07/1999WO1999000121A1 Antithrombotic agents
01/07/1999WO1999000116A2 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
01/07/1999WO1998046270A3 Polymeric conjugates polyvalently presenting an agent for therapy
01/07/1999EP0889126A2 YNL075W/HTXFT19 polypeptide
01/07/1999EP0889123A2 MurC gene of Staphylococcus aureus coding for UDP-N-acetylmuramate:L-alanine Ligase
01/07/1999EP0889122A2 Inhibition of DNA Methyltransferase
01/07/1999EP0888386A1 Stable factor viii/ von willebrand factor complex
01/07/1999EP0888381A1 Targeted therapeutic or diagnostic agents and methods of making and using same
01/07/1999EP0888353A1 Novel n-7-heterocyclyl pyrrolo 2,3-d]pyridines and their use
01/07/1999EP0888344A1 Spirocycle integrin inhibitors
01/07/1999EP0888340A1 4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists
01/07/1999EP0888302A1 N- (r)-1- 3-(4-piperidyl)propionyl-3-piperidylcarbonyl]-2(s)-acetylamino-beta-alanine as fibrinogen receptor antagonist
01/07/1999EP0888271A1 Benzamidine derivatives substituted by amino acid and hydroxy acid derivatives and their use as anti-coagulants
01/07/1999EP0784632B1 Process for extracting high-purity von willebrand factor
01/07/1999EP0528841B1 A method for the preparation of pyridoxylated hemoglobin
01/07/1999DE19728524A1 Cyclische Azapeptide Cyclic Azapeptide
01/07/1999DE19727117A1 Phenylalkylderivate, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung Phenylalkylderivate, pharmaceutical compositions containing them and methods for their preparation
01/07/1999CA2295208A1 Calcium-binding phosphoprotein
01/07/1999CA2295153A1 Antithrombotic agents
01/07/1999CA2294240A1 Antithrombotic agents
01/07/1999CA2294232A1 Carboxylic acids and derivatives thereof and pharmaceutical compositions containing them
01/07/1999CA2294126A1 Antithrombotic agents
01/07/1999CA2294042A1 Antithrombotic agents
01/07/1999CA2288744A1 Phenylalkyl derivatives, pharmaceutical compositions containing these compounds and processes for preparing them
01/06/1999CN1204369A Multi-functional hematopoietic receptor agonists
01/06/1999CN1203948A Promoter of human endoglin gene and its use
01/05/1999US5856564 Condensed benzazepine derivative and pharmaceutical composition thereof
01/05/1999US5856448 Materials involved in the control of the cardiovascular system, and in particular to activities mediated by thrombin and its cellular receptor.
01/05/1999US5856360 Pharmaceutical method for the treatment of severe blood loss and for the inhibition or treatment of hemorrhagic shock
01/05/1999US5856336 Anticholesterol agents
01/05/1999US5856316 Mixture of higher primary aliphatic alcohols, its obtention from sugar cane wax and its pharmaceutical uses
01/05/1999US5856303 Polypeptide
01/05/1999US5856297 Human C3b/C4b receptor (CR1)
01/05/1999US5856133 G-beta-gamma regulated phosphatidylinositol-3'kinase
01/05/1999US5856132 G-beta-gamma regulated phosphatidylinositol-3' kinase
01/05/1999US5856129 Hydridized detector
01/05/1999US5856126 Peptide having anti-thrombus activity and method of producing the same
01/05/1999US5856121 Nucleotide sequence
01/05/1999US5856098 Detection of this receptor variant in cells of obese individuals, and methods for treating obesity by targeting variant.
01/03/1999CA2236462A1 Murc
01/02/1999CA2221861A1 Ynl075w/htxft19
12/1998
12/30/1998WO1998058947A1 Dipeptide derivatives as growth hormone secretagogues
12/30/1998WO1998058925A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/30/1998WO1998058916A1 NEW β-AMINO AND β-AZIDOCARBOXYLIC ACID DERIVATIVES, THE PRODUCTION THEREOF AND THE USE THEREOF AS ENDOTHELIN RECEPTOR ANTAGONISTS
12/30/1998WO1998058672A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
12/30/1998WO1998058661A1 Use of fviia for the treatment of bleedings in patients with a normal blood clotting cascade and normal platelet function
12/30/1998WO1998058660A1 Pharmaceutical combination preparations containing erythropoietin and modified haemoglobins
12/30/1998WO1998058588A1 Methods and devices for providing acoustic hemostasis
12/30/1998WO1998040404A3 Secreted proteins and polynucleotides encoding them
12/30/1998EP0887416A2 Human AFC1
12/30/1998EP0887415A2 Human RCE1
12/30/1998EP0887407A2 cDNA clone HAPO167 that encodes a human 7-transmembrane receptor
12/30/1998EP0887406A2 A member of the FRZB family, franzzled
12/30/1998EP0886651A1 Persephin and related growth factors
12/30/1998EP0886648A1 Compounds and peptides that bind to the erythropoietin receptor
12/30/1998EP0886647A1 Serine protease inhibitors
12/30/1998EP0886526A1 Protection of hemopoietic cells
12/30/1998EP0577785B1 Fluorinated compounds as oxygen transport agents
12/30/1998EP0571474B1 Orthomolecular method of treating sickle cell disease
12/30/1998CN1203590A Substituted imidazoles having anti-cancer and cytokine inhibitory activity
12/30/1998CA2294259A1 Barbituric acid derivatives with antimetastatic and antitumor activity
12/30/1998CA2294138A1 Cd154 blockade therapy for therapeutic protein inhibitor syndrome
12/30/1998CA2294050A1 New .beta.-amino and .beta.-azidocarboxylic acid derivatives, the production thereof and the use thereof as endothelin receptor antagonists
12/29/1998US5854403 Method for isolation of highly pure von Willebrand Factor
12/29/1998US5854382 Bioresorbable compositions for implantable prostheses
12/29/1998US5854028 Compositions comprising IL-11 and methods of making and using IL-11
12/29/1998US5853623 Peptidyl compounds and their therapeutic use as inhibitors of metalloproteinases
12/29/1998CA2129554C Recombinant antibodies specific for tnf-.alpha.
12/29/1998CA2038888C Secretion of hirudin derivatives
12/24/1998CA2234418A1 Human afc1
12/24/1998CA2234402A1 Human rce1
12/23/1998WO1998057976A1 Secreted proteins and polynucleotides encoding them
12/23/1998WO1998057966A1 Novel aryloxy substituted pyrimidine imidazole compounds
12/23/1998WO1998057951A1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS
12/23/1998WO1998057939A1 Crystalline roxifiban
12/23/1998WO1998057937A2 Inhibitors of factor xa with a neutral p1 specificity group
12/23/1998WO1998057932A1 New amidino derivatives and their use as thrombin inhibitors
12/23/1998WO1998057678A2 Compositions containing thrombin and microfibrillar collagen
12/23/1998WO1998042754A3 Glycosaminoglycans having high antithrombotic activity
12/23/1998EP0885613A1 Use of modified hemoglobins for treatment of anemias and erythropoietin and modified hemoglobin containing combined preparations
12/23/1998EP0885299A1 Wsx receptor and ligands
12/23/1998EP0885242A1 Peptides and compounds that bind to a thrombopoietin receptor
12/23/1998EP0885215A1 Novel benzo-1,3-dioxolyl- and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
12/23/1998EP0885213A1 Fibrinogen receptor antagonists
12/23/1998EP0885205A1 Fibrinogen receptor antagonists
12/23/1998EP0885192A1 Dihydropyridine-, pyridine-, benzopyran- one- and triazoloquinazoline derivative, their preparation and their use as adenosine receptor antagonists
12/23/1998EP0885007A1 Method for separating cells, especially platelets, and bag assembly therefor
12/23/1998EP0778839B1 Novel phosphane oxides, method of preparing them and drugs containing these compounds
12/23/1998EP0722459B1 Hemoregulatory penta- or hexapeptides
12/23/1998CN1202934A Delivery of biologically active polypeptides
12/23/1998CN1202902A Thrombin inhibitors
12/23/1998CN1202893A Novel isoxazoline and isoxazole fibrinogen deceptor antagonists
12/23/1998CN1202886A 3-spiro-indolin-2-one derivatives, its preparing method and its medicinal compounds
12/23/1998CN1202823A Hydrolysis-optimized liplid emulsions and use thereof
12/23/1998CN1202799A Method for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains